The global market for Liposome Injection was valued at US$ 703 million in the year 2024 and is projected to reach a revised size of US$ 1007 million by 2031, growing at a CAGR of 5.3% during the forecast period.

Liposome Injection Market

Liposomes are lipid microcapsules composed of an amphiphilic lipid bilayer (monolayer) and/or a series of concentric discontinuous aqueous compartments separated by a series of multiple amphiphilic bilayers. In liposome drugs, the drug is contained in liposomes. In general, water-soluble drugs are often encapsulated in the aqueous compartment, and lipophilic drugs are encapsulated in the lipid bilayer of the liposome.

According to the "Global Use of Medicines 2023" released by the IQVIA Institute, the global drug expenditure in 2022 will be approximately US$1.48 trillion (excluding costs related to COVID vaccines and therapies), and it is predicted that it will grow at a rate of 3%-6% in the next few years. In terms of regional development trends, high-income countries such as Western Europe, North America, and Japan are expected to experience slower growth in the next few years due to already high per capita usage, while growth markets such as Asia, Latin America, and Eastern Europe are expected to grow strongly. In terms of drug expenditure, China"s drug expenditure in 2022 will be about 166 billion US dollars. It is expected that the expenditure on medicines will only increase in the next few years: From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines; from the perspective of national strategy, in 2016 , the State Council issued the "Healthy China 2030" Planning Outline, and "Healthy China" has risen to a national strategy; from the perspective of industry policy, it has experienced the uncertainty brought about by the initial stage of medical reform, the implementation of the centralized procurement policy and the expansion of the drug reimbursement catalog The update will gradually achieve a dynamic balance of multiple goals such as promoting innovation, stabilizing supply, and reducing the burden on the masses. Global Use of Medicines 2023 shows that, based on net ex-factory prices, the U.S. market will spend about $62.9 billion on medicines in 2022. Overall growth slows as the Inflation Reduction Act (IRA) spends $64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years, with ex-factory discounts and rebates in the drug pipeline , the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Liposome Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liposome Injection.

The Liposome Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Liposome Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Liposome Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Liposome Injection Market Report

Report Metric	Details
Report Name	Liposome Injection Market
Accounted market size in year	US$ 703 million
Forecasted market size in 2031	US$ 1007 million
CAGR	5.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Doxorubicin Hydrochloride Liposome Injection Mitoxantrone Hydrochloride Liposome Injection Irinotecan Hydrochloride Liposome Injection Others
Segment by Application	Malignant Tumor Treatment Infection Treatment Post-operative Pain Relief Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	CSPC, Luye Pharma, Fudan Zhangjiang, Nanjing Cisco, Qilu Pharmaceutical, Sichuan Kelun, Modern Medicine, Eudinamis, Indiamart, Getwelloncology, Polymun
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Liposome Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Liposome Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Liposome Injection Market growing?

Ans: The Liposome Injection Market witnessing a CAGR of 5.3% during the forecast period 2025-2031.

What is the Liposome Injection Market size in 2031?

Ans: The Liposome Injection Market size in 2031 will be US$ 1007 million.

Who are the main players in the Liposome Injection Market report?

Ans: The main players in the Liposome Injection Market are CSPC, Luye Pharma, Fudan Zhangjiang, Nanjing Cisco, Qilu Pharmaceutical, Sichuan Kelun, Modern Medicine, Eudinamis, Indiamart, Getwelloncology, Polymun

What are the Application segmentation covered in the Liposome Injection Market report?

Ans: The Applications covered in the Liposome Injection Market report are Malignant Tumor Treatment, Infection Treatment, Post-operative Pain Relief, Others

What are the Type segmentation covered in the Liposome Injection Market report?

Ans: The Types covered in the Liposome Injection Market report are Doxorubicin Hydrochloride Liposome Injection, Mitoxantrone Hydrochloride Liposome Injection, Irinotecan Hydrochloride Liposome Injection, Others

1 Liposome Injection Market Overview

1.1 Product Definition

1.2 Liposome Injection by Type

1.2.1 Global Liposome Injection Market Value Comparison by Type (2024 VS 2031)

1.2.2 Doxorubicin Hydrochloride Liposome Injection

1.2.3 Mitoxantrone Hydrochloride Liposome Injection

1.2.4 Irinotecan Hydrochloride Liposome Injection

1.2.5 Others

1.3 Liposome Injection by Application

1.3.1 Global Liposome Injection Market Value by Application (2024 VS 2031)

1.3.2 Malignant Tumor Treatment

1.3.3 Infection Treatment

1.3.4 Post-operative Pain Relief

1.3.5 Others

1.4 Global Liposome Injection Market Size Estimates and Forecasts

1.4.1 Global Liposome Injection Revenue 2020-2031

1.4.2 Global Liposome Injection Sales 2020-2031

1.4.3 Global Liposome Injection Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Liposome Injection Market Competition by Manufacturers

2.1 Global Liposome Injection Sales Market Share by Manufacturers (2020-2025)

2.2 Global Liposome Injection Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Liposome Injection Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Liposome Injection, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Liposome Injection, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Liposome Injection, Product Type & Application

2.7 Global Key Manufacturers of Liposome Injection, Date of Enter into This Industry

2.8 Global Liposome Injection Market Competitive Situation and Trends

2.8.1 Global Liposome Injection Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Liposome Injection Players Market Share by Revenue

2.8.3 Global Liposome Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Liposome Injection Market Scenario by Region

3.1 Global Liposome Injection Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Liposome Injection Sales by Region: 2020-2031

3.2.1 Global Liposome Injection Sales by Region: 2020-2025

3.2.2 Global Liposome Injection Sales by Region: 2026-2031

3.3 Global Liposome Injection Revenue by Region: 2020-2031

3.3.1 Global Liposome Injection Revenue by Region: 2020-2025

3.3.2 Global Liposome Injection Revenue by Region: 2026-2031

3.4 North America Liposome Injection Market Facts & Figures by Country

3.4.1 North America Liposome Injection Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Liposome Injection Sales by Country (2020-2031)

3.4.3 North America Liposome Injection Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Liposome Injection Market Facts & Figures by Country

3.5.1 Europe Liposome Injection Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Liposome Injection Sales by Country (2020-2031)

3.5.3 Europe Liposome Injection Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Liposome Injection Market Facts & Figures by Region

3.6.1 Asia Pacific Liposome Injection Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Liposome Injection Sales by Region (2020-2031)

3.6.3 Asia Pacific Liposome Injection Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Liposome Injection Market Facts & Figures by Country

3.7.1 Latin America Liposome Injection Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Liposome Injection Sales by Country (2020-2031)

3.7.3 Latin America Liposome Injection Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Liposome Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Liposome Injection Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Liposome Injection Sales by Country (2020-2031)

3.8.3 Middle East and Africa Liposome Injection Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Liposome Injection Sales by Type (2020-2031)

4.1.1 Global Liposome Injection Sales by Type (2020-2025)

4.1.2 Global Liposome Injection Sales by Type (2026-2031)

4.1.3 Global Liposome Injection Sales Market Share by Type (2020-2031)

4.2 Global Liposome Injection Revenue by Type (2020-2031)

4.2.1 Global Liposome Injection Revenue by Type (2020-2025)

4.2.2 Global Liposome Injection Revenue by Type (2026-2031)

4.2.3 Global Liposome Injection Revenue Market Share by Type (2020-2031)

4.3 Global Liposome Injection Price by Type (2020-2031)

5 Segment by Application

5.1 Global Liposome Injection Sales by Application (2020-2031)

5.1.1 Global Liposome Injection Sales by Application (2020-2025)

5.1.2 Global Liposome Injection Sales by Application (2026-2031)

5.1.3 Global Liposome Injection Sales Market Share by Application (2020-2031)

5.2 Global Liposome Injection Revenue by Application (2020-2031)

5.2.1 Global Liposome Injection Revenue by Application (2020-2025)

5.2.2 Global Liposome Injection Revenue by Application (2026-2031)

5.2.3 Global Liposome Injection Revenue Market Share by Application (2020-2031)

5.3 Global Liposome Injection Price by Application (2020-2031)

6 Key Companies Profiled

6.1 CSPC

6.1.1 CSPC Company Information

6.1.2 CSPC Description and Business Overview

6.1.3 CSPC Liposome Injection Sales, Revenue and Gross Margin (2020-2025)

6.1.4 CSPC Liposome Injection Product Portfolio

6.1.5 CSPC Recent Developments/Updates

6.2 Luye Pharma

6.2.1 Luye Pharma Company Information

6.2.2 Luye Pharma Description and Business Overview

6.2.3 Luye Pharma Liposome Injection Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Luye Pharma Liposome Injection Product Portfolio

6.2.5 Luye Pharma Recent Developments/Updates

6.3 Fudan Zhangjiang

6.3.1 Fudan Zhangjiang Company Information

6.3.2 Fudan Zhangjiang Description and Business Overview

6.3.3 Fudan Zhangjiang Liposome Injection Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Fudan Zhangjiang Liposome Injection Product Portfolio

6.3.5 Fudan Zhangjiang Recent Developments/Updates

6.4 Nanjing Cisco

6.4.1 Nanjing Cisco Company Information

6.4.2 Nanjing Cisco Description and Business Overview

6.4.3 Nanjing Cisco Liposome Injection Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Nanjing Cisco Liposome Injection Product Portfolio

6.4.5 Nanjing Cisco Recent Developments/Updates

6.5 Qilu Pharmaceutical

6.5.1 Qilu Pharmaceutical Company Information

6.5.2 Qilu Pharmaceutical Description and Business Overview

6.5.3 Qilu Pharmaceutical Liposome Injection Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Qilu Pharmaceutical Liposome Injection Product Portfolio

6.5.5 Qilu Pharmaceutical Recent Developments/Updates

6.6 Sichuan Kelun

6.6.1 Sichuan Kelun Company Information

6.6.2 Sichuan Kelun Description and Business Overview

6.6.3 Sichuan Kelun Liposome Injection Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Sichuan Kelun Liposome Injection Product Portfolio

6.6.5 Sichuan Kelun Recent Developments/Updates

6.7 Modern Medicine

6.7.1 Modern Medicine Company Information

6.7.2 Modern Medicine Description and Business Overview

6.7.3 Modern Medicine Liposome Injection Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Modern Medicine Liposome Injection Product Portfolio

6.7.5 Modern Medicine Recent Developments/Updates

6.8 Eudinamis

6.8.1 Eudinamis Company Information

6.8.2 Eudinamis Description and Business Overview

6.8.3 Eudinamis Liposome Injection Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Eudinamis Liposome Injection Product Portfolio

6.8.5 Eudinamis Recent Developments/Updates

6.9 Indiamart

6.9.1 Indiamart Company Information

6.9.2 Indiamart Description and Business Overview

6.9.3 Indiamart Liposome Injection Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Indiamart Liposome Injection Product Portfolio

6.9.5 Indiamart Recent Developments/Updates

6.10 Getwelloncology

6.10.1 Getwelloncology Company Information

6.10.2 Getwelloncology Description and Business Overview

6.10.3 Getwelloncology Liposome Injection Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Getwelloncology Liposome Injection Product Portfolio

6.10.5 Getwelloncology Recent Developments/Updates

6.11 Polymun

6.11.1 Polymun Company Information

6.11.2 Polymun Description and Business Overview

6.11.3 Polymun Liposome Injection Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Polymun Liposome Injection Product Portfolio

6.11.5 Polymun Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Liposome Injection Industry Chain Analysis

7.2 Liposome Injection Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Liposome Injection Production Mode & Process Analysis

7.4 Liposome Injection Sales and Marketing

7.4.1 Liposome Injection Sales Channels

7.4.2 Liposome Injection Distributors

7.5 Liposome Injection Customer Analysis

8 Liposome Injection Market Dynamics

8.1 Liposome Injection Industry Trends

8.2 Liposome Injection Market Drivers

8.3 Liposome Injection Market Challenges

8.4 Liposome Injection Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Liposome Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Liposome Injection Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Liposome Injection Market Competitive Situation by Manufacturers in 2024

Table 4. Global Liposome Injection Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Liposome Injection Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Liposome Injection Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Liposome Injection Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Liposome Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Liposome Injection, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Liposome Injection, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Liposome Injection, Product Type & Application

Table 12. Global Key Manufacturers of Liposome Injection, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Liposome Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposome Injection as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Liposome Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Liposome Injection Sales by Region (2020-2025) & (K Units)

Table 18. Global Liposome Injection Sales Market Share by Region (2020-2025)

Table 19. Global Liposome Injection Sales by Region (2026-2031) & (K Units)

Table 20. Global Liposome Injection Sales Market Share by Region (2026-2031)

Table 21. Global Liposome Injection Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Liposome Injection Revenue Market Share by Region (2020-2025)

Table 23. Global Liposome Injection Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Liposome Injection Revenue Market Share by Region (2026-2031)

Table 25. North America Liposome Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Liposome Injection Sales by Country (2020-2025) & (K Units)

Table 27. North America Liposome Injection Sales by Country (2026-2031) & (K Units)

Table 28. North America Liposome Injection Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Liposome Injection Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Liposome Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Liposome Injection Sales by Country (2020-2025) & (K Units)

Table 32. Europe Liposome Injection Sales by Country (2026-2031) & (K Units)

Table 33. Europe Liposome Injection Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Liposome Injection Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Liposome Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Liposome Injection Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Liposome Injection Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Liposome Injection Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Liposome Injection Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Liposome Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Liposome Injection Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Liposome Injection Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Liposome Injection Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Liposome Injection Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Liposome Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Liposome Injection Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Liposome Injection Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Liposome Injection Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Liposome Injection Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Liposome Injection Sales (K Units) by Type (2020-2025)

Table 51. Global Liposome Injection Sales (K Units) by Type (2026-2031)

Table 52. Global Liposome Injection Sales Market Share by Type (2020-2025)

Table 53. Global Liposome Injection Sales Market Share by Type (2026-2031)

Table 54. Global Liposome Injection Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Liposome Injection Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Liposome Injection Revenue Market Share by Type (2020-2025)

Table 57. Global Liposome Injection Revenue Market Share by Type (2026-2031)

Table 58. Global Liposome Injection Price (US$/Unit) by Type (2020-2025)

Table 59. Global Liposome Injection Price (US$/Unit) by Type (2026-2031)

Table 60. Global Liposome Injection Sales (K Units) by Application (2020-2025)

Table 61. Global Liposome Injection Sales (K Units) by Application (2026-2031)

Table 62. Global Liposome Injection Sales Market Share by Application (2020-2025)

Table 63. Global Liposome Injection Sales Market Share by Application (2026-2031)

Table 64. Global Liposome Injection Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Liposome Injection Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Liposome Injection Revenue Market Share by Application (2020-2025)

Table 67. Global Liposome Injection Revenue Market Share by Application (2026-2031)

Table 68. Global Liposome Injection Price (US$/Unit) by Application (2020-2025)

Table 69. Global Liposome Injection Price (US$/Unit) by Application (2026-2031)

Table 70. CSPC Company Information

Table 71. CSPC Description and Business Overview

Table 72. CSPC Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. CSPC Liposome Injection Product

Table 74. CSPC Recent Developments/Updates

Table 75. Luye Pharma Company Information

Table 76. Luye Pharma Description and Business Overview

Table 77. Luye Pharma Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Luye Pharma Liposome Injection Product

Table 79. Luye Pharma Recent Developments/Updates

Table 80. Fudan Zhangjiang Company Information

Table 81. Fudan Zhangjiang Description and Business Overview

Table 82. Fudan Zhangjiang Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Fudan Zhangjiang Liposome Injection Product

Table 84. Fudan Zhangjiang Recent Developments/Updates

Table 85. Nanjing Cisco Company Information

Table 86. Nanjing Cisco Description and Business Overview

Table 87. Nanjing Cisco Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Nanjing Cisco Liposome Injection Product

Table 89. Nanjing Cisco Recent Developments/Updates

Table 90. Qilu Pharmaceutical Company Information

Table 91. Qilu Pharmaceutical Description and Business Overview

Table 92. Qilu Pharmaceutical Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Qilu Pharmaceutical Liposome Injection Product

Table 94. Qilu Pharmaceutical Recent Developments/Updates

Table 95. Sichuan Kelun Company Information

Table 96. Sichuan Kelun Description and Business Overview

Table 97. Sichuan Kelun Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Sichuan Kelun Liposome Injection Product

Table 99. Sichuan Kelun Recent Developments/Updates

Table 100. Modern Medicine Company Information

Table 101. Modern Medicine Description and Business Overview

Table 102. Modern Medicine Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Modern Medicine Liposome Injection Product

Table 104. Modern Medicine Recent Developments/Updates

Table 105. Eudinamis Company Information

Table 106. Eudinamis Description and Business Overview

Table 107. Eudinamis Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Eudinamis Liposome Injection Product

Table 109. Eudinamis Recent Developments/Updates

Table 110. Indiamart Company Information

Table 111. Indiamart Description and Business Overview

Table 112. Indiamart Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Indiamart Liposome Injection Product

Table 114. Indiamart Recent Developments/Updates

Table 115. Getwelloncology Company Information

Table 116. Getwelloncology Description and Business Overview

Table 117. Getwelloncology Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Getwelloncology Liposome Injection Product

Table 119. Getwelloncology Recent Developments/Updates

Table 120. Polymun Company Information

Table 121. Polymun Description and Business Overview

Table 122. Polymun Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Polymun Liposome Injection Product

Table 124. Polymun Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Liposome Injection Distributors List

Table 128. Liposome Injection Customers List

Table 129. Liposome Injection Market Trends

Table 130. Liposome Injection Market Drivers

Table 131. Liposome Injection Market Challenges

Table 132. Liposome Injection Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

Table 136. Authors List of This Report

List of Figures

Figure 1. Product Picture of Liposome Injection

Figure 2. Global Liposome Injection Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Liposome Injection Market Share by Type: 2024 & 2031

Figure 4. Doxorubicin Hydrochloride Liposome Injection Product Picture

Figure 5. Mitoxantrone Hydrochloride Liposome Injection Product Picture

Figure 6. Irinotecan Hydrochloride Liposome Injection Product Picture

Figure 7. Others Product Picture

Figure 8. Global Liposome Injection Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Liposome Injection Market Share by Application: 2024 & 2031

Figure 10. Malignant Tumor Treatment

Figure 11. Infection Treatment

Figure 12. Post-operative Pain Relief

Figure 13. Others

Figure 14. Global Liposome Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Liposome Injection Market Size (2020-2031) & (US$ Million)

Figure 16. Global Liposome Injection Sales (2020-2031) & (K Units)

Figure 17. Global Liposome Injection Average Price (US$/Unit) & (2020-2031)

Figure 18. Liposome Injection Report Years Considered

Figure 19. Liposome Injection Sales Share by Manufacturers in 2024

Figure 20. Global Liposome Injection Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Liposome Injection Players: Market Share by Revenue in Liposome Injection in 2024

Figure 22. Liposome Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Liposome Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Liposome Injection Sales Market Share by Country (2020-2031)

Figure 25. North America Liposome Injection Revenue Market Share by Country (2020-2031)

Figure 26. United States Liposome Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Liposome Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Liposome Injection Sales Market Share by Country (2020-2031)

Figure 29. Europe Liposome Injection Revenue Market Share by Country (2020-2031)

Figure 30. Germany Liposome Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Liposome Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Liposome Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Liposome Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Liposome Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Liposome Injection Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Liposome Injection Revenue Market Share by Region (2020-2031)

Figure 37. China Liposome Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Liposome Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Liposome Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Liposome Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Liposome Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. China Taiwan Liposome Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Indonesia Liposome Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Thailand Liposome Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Malaysia Liposome Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Liposome Injection Sales Market Share by Country (2020-2031)

Figure 47. Latin America Liposome Injection Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Liposome Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Liposome Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Liposome Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Liposome Injection Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Liposome Injection Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Liposome Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Liposome Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. UAE Liposome Injection Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Liposome Injection by Type (2020-2031)

Figure 57. Global Revenue Market Share of Liposome Injection by Type (2020-2031)

Figure 58. Global Liposome Injection Price (US$/Unit) by Type (2020-2031)

Figure 59. Global Sales Market Share of Liposome Injection by Application (2020-2031)

Figure 60. Global Revenue Market Share of Liposome Injection by Application (2020-2031)

Figure 61. Global Liposome Injection Price (US$/Unit) by Application (2020-2031)

Figure 62. Liposome Injection Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Radiation Dermatitis Medicines Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33A12488

Thu Feb 13 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global 0.9% Sodium Chloride Intravenous Infusion Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-1J12515

Thu Feb 13 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Artificial Tears and Lubricants Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18Y12657

Thu Feb 13 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Drugs used for Bowel Preparation Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-39C12528

Thu Feb 13 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions